These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27570612)

  • 1. Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm?
    Marschall AL; Dübel S
    Comput Struct Biotechnol J; 2016; 14():304-8. PubMed ID: 27570612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific in vivo knockdown of protein function by intrabodies.
    Marschall AL; Dübel S; Böldicke T
    MAbs; 2015; 7(6):1010-35. PubMed ID: 26252565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances with ER Targeted Intrabodies.
    Marschall AL; Dübel S; Böldicke T
    Adv Exp Med Biol; 2016; 917():77-93. PubMed ID: 27236553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.
    Böldicke T
    J Cell Mol Med; 2007; 11(1):54-70. PubMed ID: 17367501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular antibodies (intrabodies) and their therapeutic potential.
    Lo AS; Zhu Q; Marasco WA
    Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.
    Zhang C; Ötjengerdes RM; Roewe J; Mejias R; Marschall ALJ
    BioDrugs; 2020 Aug; 34(4):435-462. PubMed ID: 32301049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders.
    Messer A; Butler DC
    Neurobiol Dis; 2020 Feb; 134():104619. PubMed ID: 31669671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules.
    Lobato MN; Rabbitts TH
    Curr Mol Med; 2004 Aug; 4(5):519-28. PubMed ID: 15267223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseases.
    Messer A; McLear J
    BioDrugs; 2006; 20(6):327-33. PubMed ID: 17176119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications.
    Cao T; Heng BC
    Ann Clin Lab Sci; 2005; 35(3):227-9. PubMed ID: 16081577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Post-translational Proteome with Intrabodies.
    Cattaneo A; Chirichella M
    Trends Biotechnol; 2019 Jun; 37(6):578-591. PubMed ID: 30577991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern biotechnology-based therapeutic approaches against HIV infection.
    Imran M; Waheed Y; Ghazal A; Ullah S; Safi SZ; Jamal M; Ali M; Atif M; Imran M; Ullah F
    Biomed Rep; 2017 Dec; 7(6):504-507. PubMed ID: 29250325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrabody applications in neurological disorders: progress and future prospects.
    Miller TW; Messer A
    Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-domain intrabodies against hepatitis C virus core inhibit viral propagation and core-induced NFκB activation.
    Suzuki R; Saito K; Matsuda M; Sato M; Kanegae Y; Shi G; Watashi K; Aizaki H; Chiba J; Saito I; Wakita T; Suzuki T
    J Gen Virol; 2016 Apr; 97(4):887-892. PubMed ID: 26861864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protein silencing switch by ligand-induced proteasome-targeting intrabodies.
    Melchionna T; Cattaneo A
    J Mol Biol; 2007 Nov; 374(3):641-54. PubMed ID: 17950312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.
    Rondon IJ; Marasco WA
    Annu Rev Microbiol; 1997; 51():257-83. PubMed ID: 9343351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions.
    Böldicke T
    Antibodies (Basel); 2022 Jul; 11(3):. PubMed ID: 35892709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.
    Gennari F; Mehta S; Wang Y; St Clair Tallarico A; Palu G; Marasco WA
    J Mol Biol; 2004 Jan; 335(1):193-207. PubMed ID: 14659750
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.